<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: bayh</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'bayh'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22bayh%22&t=%22bayh%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:42:10 +0100</lastBuildDate>
        <item>
            <title>Supreme Court Rules For Roche Over Stanford On Battle Over Patents &amp; Federally Funded Research</title>
            <link>http://www.medworm.com/index.php?rid=4902691&amp;cid=t_279267_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fq9blxr54E9o%2F</link>
            <description>The US Supreme Court ruled today that Stanford University is unable to win a patent infringement case against a Roche unit because the subsidiary held co-ownership interests in the patents. The case was being closely watched for clues to clarifying the implications of a 1980 law that allocates patent rights among the government, investors and institutions that receive federal funding.
Here’s the background: Stanford sued Roche in 2005 for patent infringement over technology to detect HIV levels blood using PCR, or polymerase chain reaction. The underlying discovery was made years earlier by a Stanford researcher, Mark Holodniy, who also worked with a company called Cetus that was later bought by Roche. However, the initial funding came from the federal government.
The dispute centered on...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4902691</comments>
            <pubDate>Mon, 06 Jun 2011 16:58:19 +0100</pubDate>
            <guid isPermaLink="false">4902691</guid>        </item>
        <item>
            <title>Why Joe Carik Is Fighting Over A Genzyme Drug</title>
            <link>http://www.medworm.com/index.php?rid=4704960&amp;cid=t_279267_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FIe-9hJBgDxE%2F</link>
            <description>Over the past fewl months, several patients suffering from Fabry disease – a rare, inherited disorder that causes kidney and heart problems – have tried different ways to get a needed medication called Fabrazyme. The drug, which is made by Genzyme, has been rationed due to severe manufacturing problems that led to a consent decree for the biotech, which is now part of Sanofi-Aventis. Twice, the patients have petitioned the National Institutes of Health to allow them to break a patent; they have also petitioned the FDA to insist that overseas stock of the med is first made available to US citizens, and they are suing Genzyme and Mt. Sinai Medical Center in New York, which licensed Fabrazyme to Genzyme (back story). The outcome of their efforts is unclear, although they say Fabry patient...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4704960</comments>
            <pubDate>Mon, 11 Apr 2011 16:07:44 +0100</pubDate>
            <guid isPermaLink="false">4704960</guid>        </item>
        <item>
            <title>Who Owns Patents Generated By Federal Dollars?</title>
            <link>http://www.medworm.com/index.php?rid=4517350&amp;cid=t_279267_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fh1PK0AihVGc%2F</link>
            <description>On Monday, the US Supreme Court will hear this debate, which involves a dispute between Roche and Stanford University over the rights to HIV test kits (see here). The case is expected to clarify the implications of a 1980 law that allocates patent rights among the government, investors and institutions that receive federal funding.
Here’s the background: Stanford sued Roche in 2005 for patent infringement over technology to detect HIV levels blood using PCR, or polymerase chain reaction. The underlying discovery was made years earlier by a Stanford researcher, Mark Holodniy, who also worked with a company called Cetus that was later bought by Roche. However, the initial funding came from the federal government.
At issue is whether Holodniy had the right to assign his interest to Cetus or...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4517350</comments>
            <pubDate>Thu, 24 Feb 2011 15:41:53 +0100</pubDate>
            <guid isPermaLink="false">4517350</guid>        </item>
        <item>
            <title>Activists Seek To Break Patent On Abbott AIDS Drug</title>
            <link>http://www.medworm.com/index.php?rid=3965695&amp;cid=t_279267_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FrIq-yS7snsQ%2F</link>
            <description>In response to US pricing of the Norvir AIDS drug sold by Abbott Laboratories, an advocacy group plans to petition the National Institutes of Health this month to break several patents on the drug. The forthcoming move by Knowledge Ecology International comes six years after the group failed at a similar attempt to convince the agency to override patents held by the drugmaker on the grounds that a recent 400 percent price hike was unreasonable, anticompetitive and threatened the health and safety of people with AIDS (here is the 2004 petition and the NIH denial). 
In a recent report, however, KEI notes that for patients without some form of government assistance or insurance, Norvir continues to cost much more than in other countries, both those are that considered developed and less-devel...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3965695</comments>
            <pubDate>Tue, 14 Sep 2010 12:13:13 +0100</pubDate>
            <guid isPermaLink="false">3965695</guid>        </item>
        <item>
            <title>Patients Seek To Break Patent On Genzyme Drug</title>
            <link>http://www.medworm.com/index.php?rid=3816760&amp;cid=t_279267_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FP6EAlh1LFi0%2F</link>
            <description>Frustrated by the ongoing shortage of Genzyme&amp;#8217;s Fabrazyme medication for Fabry&amp;#8217;s disease, three patients have petitioned the US Department of Health and Human Services to override the use patents held by the troubled biotech. Their hope is to find a way to produce the drug, which is the only such treatment currently available for a rare, inherited disorder that causes kidney and heart problems. 
The move comes after a year of turmoil at Genzyme, which recently agreed to pay $175 million as part of a consent decree for a raft of manufacturing problems, including viral contamination and even bits of trash found in some products. The gaffes prompted outrage from some large investors, a proxy fight by Carl Icahn and helped set the stage for the takeover bid by Sanofi-Aventis (backg...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3816760</comments>
            <pubDate>Tue, 03 Aug 2010 13:10:38 +0100</pubDate>
            <guid isPermaLink="false">3816760</guid>        </item>
        <item>
            <title>Patent Ownership And Federally Funded Research</title>
            <link>http://www.medworm.com/index.php?rid=3618088&amp;cid=t_279267_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fnm5I0QP2L3Y%2F</link>
            <description>Who owns patents that are generated by federally funded research? Roche has just filed a brief in a case before the US Supreme Court in hopes of deciding the question. The drugmaker is fighting Stanford University, which sued Roche in 2005 for patent infringement over technology to detect HIV levels blood using PCR, the polymerase chain reaction, The Tech writes.
Roche claims it is a co-owner of the patent because one of the original researchers transferred his patent rights to Cetus, which the drugmaker later purchased. In its brief, Roche argues the Bayh-Dole Act &amp;#8220;does not alter a co-inventor’s right to assign his shared interests in an invention&amp;#8221; and that “despite numerous requests, Stanford has never produced the actual funding agreement with the federal government that...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3618088</comments>
            <pubDate>Tue, 01 Jun 2010 14:03:45 +0100</pubDate>
            <guid isPermaLink="false">3618088</guid>        </item>
        <item>
            <title>Evan Bayh and Congressional Comity</title>
            <link>http://www.medworm.com/index.php?rid=3279964&amp;cid=t_279267_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FBzJWdwppBd8%2F</link>
            <description>By Roger PilonToday Politico Arena asks:
Is Bayh&amp;#8217;s lament on target?
My response:
The heart of Evan Bayh&amp;#8217;s surprising announcement yesterday that he would not be seeking another term in the Senate was captured in three short sentences:
For some time, I have had a growing conviction that Congress is not operating as it should.  There is too much partisanship and not enough progress &amp;#8212; too much narrow ideology and not enough practical problem-solving.  Even at a time of enormous challenge, the peoples’ business is not being done.
Beguilingly attractive as those sentiments may be, suggesting that some Golden Age of congressional comity has been lost, a candid look at our history shows that comity has been the exception, not the rule.  And it&amp;#8217;s occurred mainly w...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3279964</comments>
            <pubDate>Tue, 16 Feb 2010 19:50:09 +0100</pubDate>
            <guid isPermaLink="false">3279964</guid>        </item>
        <item>
            <title>Baucus Bill’s Spending Cuts Won’t Stick</title>
            <link>http://www.medworm.com/index.php?rid=2876016&amp;cid=t_279267_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FX_v6kv5I570%2F</link>
            <description>Why? Just ask Sen. Evan Bayh (D-IN):
You can sort of see this coming. The savings from the pharmaceutical companies and the insurance industry, you can kind of count on that because they&amp;#8217;re not very popular.
The hospitals are a different story.  People, you know, like their hospitals; they tend to trust their hospitals. The hospitals have pledged big savings. I can easily forecast at some point in the not-too-distant future the hospitals coming in and saying, &amp;#8220;You know what, this isn&amp;#8217;t working exactly the way we expected. Please spare us from this,&amp;#8221; and them getting a good hearing in [Congress].
The same thing goes for physicians.
And the pharmaceutical companies.
And the insurance industry. (Source: Cato-at-liberty)</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2876016</comments>
            <pubDate>Fri, 09 Oct 2009 10:14:15 +0100</pubDate>
            <guid isPermaLink="false">2876016</guid>        </item>
        <item>
            <title>Senator Evan Bayh Steps Up Fight Against Alzheimer’s Disease</title>
            <link>http://www.medworm.com/index.php?rid=2703944&amp;cid=t_279267_137_f&amp;fid=35426&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FTheAlzheimersReadingRoom%2F%7E3%2F6ZOpT0nWs14%2Fsenators-evan-bayh-steps-up-fight.html</link>
            <description>Earlier this week I posted, Senators Bayh, Martinez Step Up Fight Against Alzheimer’s Disease.If you would like to write a note to Senator Evan Bayh on his Facebook page go here.If you would like to email Senator Bayh go here.If you would like to contact your Senator concerning this legislation or Alzheimer's go here.If you would like to contact your U.S. Representative concerning this legislation or Alzheimer's go here.Unfortunatly, Senator Mel Martinez resigned this week.Advice and Insight into Alzheimer's diseaseSubscribe to The Alzheimer's Reading RoomMore from the Alzheimer's Reading RoomThe Alzheimer's Reading Room--Press ReleaseTest Your Memory (TYM) for Alzheimer's or Dementia in Five MinutesQuestions About Test Your Memory (TYM) for Alzheimers and DementiaDimebon Clinical Trial?...</description>
            <author>Alzheimer's Reading Room, The</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2703944</comments>
            <pubDate>Sat, 15 Aug 2009 15:18:02 +0100</pubDate>
            <guid isPermaLink="false">2703944</guid>        </item>
        <item>
            <title>Senators Bayh, Martinez Step Up Fight Against Alzheimer’s Disease</title>
            <link>http://www.medworm.com/index.php?rid=2688881&amp;cid=t_279267_137_f&amp;fid=35426&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FTheAlzheimersReadingRoom%2F%7E3%2Fu00JXHL-huM%2Fsenators-bayh-martinez-step-up-fight.html</link>
            <description>Now for some good news.“Alzheimer’s causes a tremendous emotional strain to the families caring for patients, and a financial strain on our nation’s already stressed health care system. With the number of Alzheimer’s patients on the rise and the federal government spending an estimated one hundred billion dollars on their care this year, we must increase our efforts to detect and combat this disease. Establishing the Office of the National Alzheimer’s Project in the White House will accelerate the development of cutting edge medical treatments to fight Alzheimer’s and improve patient care for the 5.3 million Americans and their families who bravely confront this disease every day.”Advice and Insight into Alzheimer's diseaseSubscribe to The Alzheimer's Reading RoomWashington ...</description>
            <author>Alzheimer's Reading Room, The</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2688881</comments>
            <pubDate>Mon, 10 Aug 2009 19:45:00 +0100</pubDate>
            <guid isPermaLink="false">2688881</guid>        </item>
        <item>
            <title>Barack Obama Watch: The Real Vice President?</title>
            <link>http://www.medworm.com/index.php?rid=1497381&amp;cid=t_279267_125_f&amp;fid=34819&amp;url=http%3A%2F%2Fflapsblog.com%2F2008%2F06%2F05%2Fbarack-obama-watch-the-real-vice-president%2F</link>
            <description>Photo Courtesy of Skeptical Brotha
Is Team Obama &amp;#8220;FIGHTING OFF&amp;#8221; the Clintons for payment of their campaign debt by channeling Senator James Webb for Vice President?
Another way to stop the Hillary-for-Veep speculation: Fire up some other speculation.
And so Obama announced this morning that he&amp;#8217;d be campaigning in Virginia with Senator Jim Webb and former Governor Mark Warner.
Senator Webb has been touted as the Vice Presidential candidate who best augments the lack of military experience of Obama, comes from a possible pick-up state in the Electoral College, Virginia, and is a former Reagan Republican.
Flap thinks Webb is in the running and look at what Intrade says this morning:

As of this morning, Webb&amp;#8217;s stock is up and Hillary&amp;#8217;s is down. Obama has to balan...</description>
            <author>FullosseousFlap's Dental Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1497381</comments>
            <pubDate>Thu, 05 Jun 2008 13:47:08 +0100</pubDate>
            <guid isPermaLink="false">1497381</guid>        </item>
        <item>
            <title>Indiana Senator Evan Byah Says GOP May “Swift Boat” Obama Over Jeremiah Wright</title>
            <link>http://www.medworm.com/index.php?rid=1411738&amp;cid=t_279267_125_f&amp;fid=34819&amp;url=http%3A%2F%2Fflapsblog.com%2F%3Fp%3D6889</link>
            <description>Dan Balz of the Washington Post interviews Indiana Democrat Senator Evan Byah
Hillary Clinton surrogate and Superdelegate Indiana Senator Evan Byah today warns that the GOP may &amp;#8220;Swift Boat&amp;#8221; Barack Obama over the Jeremiah Wright Flap.
Sen. Evan Bayh (D-Ind.) today praised Sen. Barack Obama for denouncing his former pastor, but warned that Republicans will use the association to try to &amp;#8220;Swift Boat&amp;#8221; the Illinois senator if he becomes the Democratic presidential nominee this fall.
Bayh, who is supporting Sen. Hillary Rodham Clinton for president, said he hoped other issues &amp;#8212; the economy, gasoline prices, health care and the cost of college &amp;#8212; will drive the decisions of most voters in Tuesday&amp;#8217;s Indiana primary. Obama has struggled in other states to win...</description>
            <author>FullosseousFlap's Dental Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1411738</comments>
            <pubDate>Thu, 01 May 2008 02:07:00 +0100</pubDate>
            <guid isPermaLink="false">1411738</guid>        </item>
        <item>
            <title>Hillary Clinton Watch: On To Indiana</title>
            <link>http://www.medworm.com/index.php?rid=1393687&amp;cid=t_279267_125_f&amp;fid=34819&amp;url=http%3A%2F%2Fflapsblog.com%2F%3Fp%3D6816</link>
            <description>Democratic presidential hopeful, Sen. Hillary Rodham Clinton, D-N.Y., addresses employees during a campaign stop as Sen. Evan Bayh, D-Ind., right, listens at AM General Assembly Plant, in Mishawaka, Ind., Saturday, April 12, 2008.
After yesterday&amp;#8217;s Pennsylvania Democrat primary election victory it is on to Indiana for Senator Hillary Clinton. She won&amp;#8217;t win North Carolina which votes prior because of its large African American population that votes 95+ per cent for Obama but Indiana will be a battleground.
At present Hillary has a slight lead in the polls.
But, she has the endorsement and active campaign support of popular Indiana Senator Evan Bayh. Flap thinks should Clinton win the nomination that Bayh will be her Vice President choice.
The Democrat presidential primary electi...</description>
            <author>FullosseousFlap's Dental Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1393687</comments>
            <pubDate>Wed, 23 Apr 2008 17:07:27 +0100</pubDate>
            <guid isPermaLink="false">1393687</guid>        </item>
        <item>
            <title>Hillary Clinton Watch: Winning in the Electoral College</title>
            <link>http://www.medworm.com/index.php?rid=1323127&amp;cid=t_279267_125_f&amp;fid=34819&amp;url=http%3A%2F%2Fflapsblog.com%2F%3Fp%3D6647</link>
            <description>Sen. Evan Bayh, D-Ind., right, speaks to the crowd at Anderson High School&amp;#8217;s gymnasium Thursday, March 20, 2008 as he and Democratic presidential hopeful, Sen. Hillary Rodham Clinton, D-N.Y., campaign in Anderson, Ind.

With the deepening Democrat Party dilemma with Hillary Clinton and Barack Obama, Hillary has resorted to an argument of electability of her candidacy in the Electoral College.
Senator Evan Bayh of Indiana, who backs Senator Hillary Rodham Clinton for president, proposed another gauge Sunday by which superdelegates might judge whether to support Mrs. Clinton or Senator Barack Obama.
He suggested that they consider the electoral votes of the states that each of them has won.
“So who carried the states with the most Electoral College votes is an important factor to con...</description>
            <author>FullosseousFlap's Dental Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1323127</comments>
            <pubDate>Mon, 24 Mar 2008 21:15:41 +0100</pubDate>
            <guid isPermaLink="false">1323127</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… Weekend Round-Up</title>
            <link>http://www.medworm.com/index.php?rid=1097779&amp;cid=t_279267_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F201367795%2F</link>
            <description>As the weekend draws to a close, this may be a good time to catch up on events and other items of interest. And for those with a keen interest in the ongoing controversy over antidepressants and suicidal thoughts among youngsters, we are told that the Fox News show, Hannity&amp;#8217;s America, will take a look at how the issue is being tied to several school shootings. However, the segment doesn&amp;#8217;t yet appear on the web site&amp;#8217;s schedule, but if our info is correct, it would air at 9 pm EST. 
Evan Bayh is a Democratic senator from Indiana. His wife, Susan Bayh, is something of a professional board member, earning more than $1 million annually in director fees at companies that make pharmaceuticals, operate radio stations, sell health insurance, offer online banking and distribute ing...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1097779</comments>
            <pubDate>Sun, 16 Dec 2007 23:14:47 +0100</pubDate>
            <guid isPermaLink="false">1097779</guid>        </item>
    </channel>
</rss>

